Bendamustine Cyclopolysaccharide Compositions

Patent No. EP2792369 (titled "Bendamustine Cyclopolysaccharide Compositions") was filed by Softkemo Pharma on Feb 24, 2010. The application was issued on Apr 18, 2018.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Company	Opposition Date	Representative
INTAS PHARMACEUTICALS	Jan 17, 2019	ACCORD HEALTHCARE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

Date
Description

Get instant alerts for new documents

Jul 10, 2020
Communication to the parties concerning termination of the opposition proceedings - opposition rejected - no appeal lodged
Jul 10, 2020
Communication to the parties concerning the termination of the opposition proceedings (opponent)
Jul 7, 2020
Termination of the opposition proceedings with maintenance of patent
Mar 12, 2020
Advice of delivery
Mar 5, 2020
Advice of delivery
Feb 28, 2020
Acknowledgement of a document
Feb 28, 2020
Acknowledgement of a document
Feb 28, 2020
Decision of the Opposition Division and instruction
Feb 28, 2020
Decision rejecting the opposition
Feb 28, 2020
Grounds for the decision (Annex) - opposition
Feb 28, 2020
Internal form - Opposition/addressees
Feb 28, 2020
Means of redress
Jan 31, 2020
Notification concerning the date of oral proceedings
Jan 31, 2020
Notification concerning the date of oral proceedings
Jan 8, 2020
Brief communication - Opposition proceedings
Dec 20, 2019
(Electronic) Receipt
Dec 20, 2019
Amended claims with annotations
Dec 20, 2019
Citation in opposition procedure - 008
Dec 20, 2019
Citation in opposition procedure - 011
Dec 20, 2019
Claims
Dec 20, 2019
Consolidated list of cited opposition documents
Dec 20, 2019
Letter accompanying subsequently filed items
Dec 20, 2019
Written submission in preparation to/during oral proceedings
Dec 12, 2019
Brief communication - Opposition proceedings
Dec 9, 2019
(Electronic) Receipt
Dec 9, 2019
Letter accompanying subsequently filed items
Dec 9, 2019
Written submission in preparation to/during oral proceedings
Sep 11, 2019
Advice of delivery
Aug 21, 2019
Advice of delivery
Aug 19, 2019
Advice of delivery
Aug 13, 2019
Advice of delivery
Aug 6, 2019
Acknowledgement of a document
Aug 6, 2019
Acknowledgement of a document
Aug 6, 2019
Annex to the communication - opposition
Aug 6, 2019
Information concerning oral proceedings
Aug 6, 2019
Summons to attend oral proceedings
Aug 6, 2019
Summons to attend oral proceedings
Jun 13, 2019
Brief communication - Opposition proceedings
Jun 7, 2019
(Electronic) Receipt
Jun 7, 2019
Amended claims with annotations
Jun 7, 2019
Amended claims with annotations
Jun 7, 2019
Amended claims with annotations
Jun 7, 2019
Citation in opposition procedure - 010
Jun 7, 2019
Claims
Jun 7, 2019
Claims
Jun 7, 2019
Claims
Jun 7, 2019
Letter accompanying subsequently filed items
Jun 7, 2019
Reply of the patent proprietor to the notice(s) of opposition
Feb 4, 2019
Communication of a notice of opposition and request to file observations
Feb 4, 2019
Notice of further oppositions to opponent(s)
Jan 30, 2019
Communication of a notice of opposition - first information to patent proprietor
Jan 17, 2019
(Electronic) Receipt
Jan 17, 2019
Citation in opposition procedure - 001
Jan 17, 2019
Citation in opposition procedure - 002
Jan 17, 2019
Citation in opposition procedure - 003
Jan 17, 2019
Citation in opposition procedure - 004
Jan 17, 2019
Citation in opposition procedure - 005
Jan 17, 2019
Citation in opposition procedure - 006
Jan 17, 2019
Citation in opposition procedure - 007
Jan 17, 2019
Citation in opposition procedure - 008
Jan 17, 2019
Citation in opposition procedure - 009
Jan 17, 2019
Letter accompanying subsequently filed items
Jan 17, 2019
Notice of opposition
Jan 17, 2019
Notice of opposition
Apr 30, 2018
Transmission of the certificate for a European patent pursuant to Rule 74 EPC
Mar 22, 2018
Decision to grant a European patent
Mar 5, 2018
(Electronic) Receipt
Mar 5, 2018
Filing of the translations of the claims
Mar 5, 2018
French translation of claims
Mar 5, 2018
German translation of the claims
Mar 5, 2018
Letter accompanying subsequently filed items
Dec 14, 2017
Communication of the registration of a transfer or change of name and/or address
Dec 4, 2017
(Electronic) Receipt
Dec 4, 2017
Annexes in respect of a client data request
Dec 4, 2017
Letter accompanying subsequently filed items
Dec 4, 2017
Submission concerning a transfer of rights (applicant)
Nov 8, 2017
Bibliographic data of the European patent application
Nov 8, 2017
Communication about intention to grant a European patent
Nov 8, 2017
Intention to grant (signatures)
Nov 8, 2017
Text intended for grant (clean copy)
Nov 8, 2017
Text intended for grant (version for approval)
May 12, 2017
(Electronic) Receipt
May 12, 2017
Letter accompanying subsequently filed items
May 12, 2017
Reply to communication from the Examining Division
Mar 29, 2017
Request for extension of time limit to communication from the Examining Division
Mar 22, 2017
Grant of extension of time limit (examination procedure)
Mar 17, 2017
Request for extension of time limit to communication from the Examining Division
Nov 21, 2016
Annex to the communication
Nov 21, 2016
Communication from the Examining Division
Dec 3, 2015
(Electronic) Receipt
Dec 3, 2015
Amended claims with annotations
Dec 3, 2015
Claims
Dec 3, 2015
Letter accompanying subsequently filed items
Dec 3, 2015
Reply to communication from the Examining Division
Oct 29, 2015
Grant of extension of time limit (examination procedure)
Oct 29, 2015
Request for extension of time limit to communication from the Examining Division
Oct 23, 2015
Request for extension of time limit to communication from the Examining Division
Jun 17, 2015
Annex to the communication
Jun 17, 2015
Communication from the Examining Division
May 4, 2015
Examination started
Apr 14, 2015
(Electronic) Receipt
Apr 14, 2015
Letter concerning fees and payments
Apr 14, 2015
Maintenance of the application
Apr 7, 2015
Notice drawing attention to the payment of the renewal fee and additional fee
Oct 27, 2014
Reminder period for payment of examination fee/designation fee and correction of deficiencies in Written Opinion/amendment
Oct 1, 2014
Refund of fees
Sep 24, 2014
Notification of forthcoming publication
Sep 23, 2014
Communication to designated inventor
Sep 23, 2014
Communication to designated inventor
Sep 23, 2014
Communication to designated inventor
Sep 23, 2014
Communication to designated inventor
Sep 12, 2014
Communication regarding the transmission of the European search report
Sep 12, 2014
European search opinion
Sep 12, 2014
European search report
Sep 1, 2014
Search started
Jul 16, 2014
Abstract
Jul 16, 2014
Acknowledgement of receipt of electronic submission of the request for grant of a European patent
Jul 16, 2014
Claims
Jul 16, 2014
Description
Jul 16, 2014
Designation of inventor
Jul 16, 2014
Designation of inventor
Jul 16, 2014
Designation of inventor
Jul 16, 2014
Designation of inventor
Jul 16, 2014
Request for grant of a European patent
Sep 20, 2010
Priority document (electronically transmitted)
Sep 20, 2010
Priority document (electronically transmitted)
Sep 20, 2010
Priority document (electronically transmitted)
Sep 20, 2010
Priority document (electronically transmitted)

EP2792369

SOFTKEMO PHARMA

Application Number: EP14177306A
Filing Date: Feb 24, 2010
Status: Opposition Rejected; Jul 10, 2020
Publication Date: Apr 18, 2018
External Links: Slate, Register , Google Patents

IP Verse

Bendamustine Cyclopolysaccharide Compositions

Patent Summary

Patent Family

Patent Oppositions

Dossier Documents

EP2792369